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ABSTRACT OF THESIS 
 
 
 
 
BREAST CANCER TRENDS AMONG KENTUCKY WOMEN, 2004-2007  
 
 
The purpose of this study is to investigate the discrepancies of female breast cancer 
mortality between the Appalachian and Non-Appalachian regions of Kentucky using 
data from the Kentucky Cancer Registry. This study identified subtype, reproductive, 
and regional differences in women with breast cancer in Kentucky.  Among women 
with breast cancer living in Kentucky from 2004 to 2007, one and three live births 
significantly increased a woman’s risk of breast cancer mortality by 91% and 58% 
respectively, compared to a woman with zero live births. Progesterone receptor-
negative tumor status significantly increased a woman’s risk of breast cancer 
mortality by 64% compared to women with progesterone receptor-positive breast 
cancer. Residence in the Appalachian region significantly increased a woman’s risk 
of breast cancer mortality by 3.14-fold.  After adjusting for regional interactions, 
progesterone receptor-negative tumor status in the Appalachian region increased a 
woman’s risk of breast cancer mortality by 3.13-fold.  These findings suggest parity 
and estrogen receptor tumor status do not contribute to the breast cancer differences 
between the Appalachian and Non-Appalachian region of Kentucky.  The association 
between progesterone receptor status and Appalachian residency suggest factors 
associated with the Appalachian region provide the poorest prognosis for a woman 
with breast cancer in Kentucky. 
 
KEYWORDS: Breast cancer, Mortality, Appalachia, Parity, Progesterone 
 
 
 
Kara Ann Hagan 
        December 8, 2011
  
BREAST CANCER TRENDS AMONG KENTUCKY WOMEN, 2004-2007 
 
 
 
By 
Kara Ann Hagan 
 
        
 
 
 
 
 
 
 
 
 
      Kelly H Webber, PhD, MPH, RD, LD 
       Director of Thesis  
     
Kwaku Addo, PhD    
       Director of Graduate Studies 
       
      December 8, 2011    
       Date 
 
          
  
 
 
DEDICATIONS 
- - - - - 
In memory of my grandfather 
Robert Michael Hagan 
1947 – 2000 
& 
My lovely grandmother and three-time breast cancer survivor 
Lois Ann Hagan 
  
v 
 
ACKNOWLEDGEMENTS 
The successful completion of the following thesis would have not been feasible 
without the support and direction of many key people.  First and foremost I want to thank 
my Thesis Chair, Dr. Kelly Webber.  I am sincerely grateful for the guidance and 
motivation throughout my academic career and in the preparation of my thesis.  I am also 
thankful for the example she has provided as a successful woman researcher and 
professor.   Next, I want to thank Dr. Alison Gustafson, whose significant contributions 
and invaluable guidance allowed me to see this project to completion, as well as, Dr. 
Kwaku Addo, for his words of encouragement and participation on my thesis committee.  
In addition to my thesis committee members, I have been blessed to have three 
important mentors that have been monumental in my academic career at the University of 
Kentucky. Dr. Sandra Bastin, you are an inspiration.  Thank you for inspiring me to be a 
leader to others and to never give up on my dreams.  Dr. Tammy Stephenson, without 
you, I don’t think I would have made it through graduate school.  Thank you for always 
being in my corner.  And, Dr. Bernhard Hennig, because of you, I was able to realize my 
full potential as a student and teacher to others.    
I also wish to thank the Kentucky Cancer Registry for providing the breast cancer 
data and the KCR staff for their time and advice on this project.  I also must thank all of 
the NFS faculty and staff for their support during my academic career. 
Finally, my deepest gratitude goes to my parents, family, friends and fellow 
graduate students for their love and support.  I hope that I continue to make you proud.   
And last but not least, Michael, whose patient love enabled me to complete this project.  
My success is nothing without you. 
vi 
 
TABLE OF CONTENTS 
Dedications ........................................................................................................................ iv	  
Acknowledgements ............................................................................................................. v	  
List of Tables ................................................................................................................... viii	  
Chapter One ........................................................................................................................ 1	  
Introduction ..................................................................................................................... 1	  
Background ................................................................................................................. 1	  
Statement of the Purpose ............................................................................................. 1	  
Research Questions ..................................................................................................... 2	  
Justification ................................................................................................................. 2	  
Assumptions ................................................................................................................ 3	  
Chapter Two ........................................................................................................................ 4	  
Literature Review ........................................................................................................... 4	  
Pathology of cancer ..................................................................................................... 4	  
Tumor receptors .......................................................................................................... 5	  
Reproductive factors ................................................................................................... 6	  
Regional Differences ................................................................................................... 7	  
Tumor Classifications by Stage and Grade ................................................................. 9	  
Chapter Three .................................................................................................................... 12	  
Methodology ................................................................................................................. 12	  
Research Methods ..................................................................................................... 12	  
Research Scope ......................................................................................................... 12	  
Study Population ....................................................................................................... 12	  
Statistical Analysis .................................................................................................... 13	  
Chapter Four ..................................................................................................................... 16	  
Results ........................................................................................................................... 16	  
Demographics ........................................................................................................... 16	  
Reproductive Differences ......................................................................................... 18	  
Tumor Receptor Status .............................................................................................. 20	  
Regional Differences ................................................................................................. 21	  
Chapter Five ...................................................................................................................... 24	  
Discussion ..................................................................................................................... 24	  
Chapter Six ........................................................................................................................ 28	  
Conclusion .................................................................................................................... 28	  
Appendices ........................................................................................................................ 31	  
Appendix A: IRB Approval Documentation ............................................................ 31	  
Appendix B:  Definition of Terms ............................................................................ 32	  
vii 
 
Bibliography ..................................................................................................................... 33	  
Vita .................................................................................................................................... 38	  
 
  
viii 
 
LIST OF TABLES 
Table 1. Demographic Characteristics of Breast Cancer Registry Patients in Kentucky, 
2004-2007.  17 
Table 2. Number of Live Births and Odds Ratio of Breast Cancer Mortality among Adult 
Women in Kentucky, 2004-2007.  19 
Table 3. Receptor type and Odds Ratio of Breast Cancer Mortality among Adult Women 
in Kentucky, 2004-2007.  21 
Table 4. Residence in Kentucky and Odds Ratio of Breast Cancer Mortality among Adult 
Women in Kentucky, 2004-2007.  23 
 
 
1 
 
CHAPTER ONE 
Introduction  
Background 
Breast cancer is the most commonly occurring cancer among women in Kentucky 
(Centers for Disease Control and Prevention [CDC], 2010). Research has associated 
unfavorable socioeconomic and reproductive factors with an increased risk of female 
breast cancer and incidence of specific tumor markers (L. Vona-Davis et al., 2008).  Non-
Appalachian regions have higher incidence rates, whereas Appalachian women 
experience higher breast cancer mortality rates (Appalachian Regional Commission 
[ARC], 2004).  These Appalachian regions of Kentucky are known to have decreased 
access to health care, lower personal incomes, and lower rates of breast cancer screening 
(Hall, Uhler, Coughlin, & Miller, 2002; McGarvey, Killos, & Cohn, 2011; Wingo et al., 
2008). Other factors unique to the Appalachian region may be significant predictors of 
breast cancer incidence and mortality (Katz et al., 2010; McGarvey, et al., 2011).  
Therefore, studying how these risk factors predict the vital status of Kentucky women 
with breast cancer can aid health professionals in developing educational and 
preventative techniques to decrease incidence and mortality in both Appalachian and 
Non-Appalachian regions of Kentucky.  
Statement of the Purpose 
The purpose of this study is to investigate the breast cancer mortality rate 
differences among women living in the Appalachian and Non-Appalachian regions of 
Kentucky.  By investigating the subtype, lifestyle, and reproductive differences between 
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the two regions of Kentucky, investigators and health care professionals can focus their 
education efforts, screening procedures, and prevention efforts to the needs of each 
region 
Research Questions 
1. Does the number of live births have an effect on the breast cancer mortality 
variation among adult women with breast cancer living in Kentucky? 
2. Does the tumor receptor status have an effect on mortality in women with breast 
cancer living in Kentucky?  
3. What factors contribute to the mortality difference between the Appalachian and 
Non-Appalachian region in women with breast cancer living in Kentucky? 
Justification 
Kentucky is the only state out of the six main Appalachian states, which includes 
Ohio, Pennsylvania, Virginia, New York, and West Virginia, whose breast cancer 
mortality rate is greater in the Appalachian region than the Non-Appalachian region of 
the state (Appalachian Community Cancer Network [ACCN], 2010; ARC, 2009).   
Research efforts have established socioeconomic, lifestyle, and reproductive factors to be 
associated with mortality and incidence rates in other Appalachian states (Abraham et al., 
2009; Katz, et al., 2010; McGarvey, et al., 2011).  However, limited research is available 
defining the regional differences of breast cancer mortality between the Appalachian and 
Non-Appalachian region of Kentucky (Burris & Andrykowski, 2010; Wingo, et al., 
2008).  Thus, research efforts are warranted to explain the relationship of risk factors with 
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breast cancer mortality in both the Appalachian and Non-Appalachian regions of 
Kentucky in order to help decrease overall breast cancer mortality rates in Kentucky. 
Assumptions 
This study assumed all data collected by the Kentucky Cancer Registry was 
accurate.  Secondly, the study also assumes records that were excluded did not skew the 
results. Lastly, the study concludes breast cancer mortality in the current cases and future 
cases would be related to the diagnosis of breast cancer.  
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CHAPTER TWO 
Literature Review 
Breast cancer mortality rates in Appalachia Kentucky are significantly higher than 
rates in Non-Appalachian regions of the state (Wingo, et al., 2008).   Though smoking, 
family history, and personal history are established risk factors of female breast cancer 
incidence, mortality rate discrepancies of breast cancer between Appalachian and Non-
Appalachian regions may be linked to reproductive, subtype, or socioeconomic regional 
differences (Luo et al., 2011; McDavid, Tucker, Sloggett, & Coleman, 2003; Phipps et 
al., 2011; L Vona-Davis & Royce, 2009).  The study of these regional differences may 
provide insights into understanding and minimizing the risk factors associated with 
aggressive breast cancer subtypes.   
Pathology of Cancer 
The pathology of cancer is an important focus in the research of breast cancer. 
Understanding the pathology of breast cancer is essential in the prevention and reduction 
of breast cancer, as well as treatment efforts for breast cancer (Lari & Kuerer, 2011; 
Ursin et al., 2005).    
Current research hypothesizes that mutations in tumor suppressing genes, 
imbalances of regulating proteins, and over expressions of tumor receptors are involved 
in the proliferation mechanism (Lari et al, 2011).    Breast cancer research links increased 
endogenous estrogen and progesterone levels with decreased cell adhesion and increased 
trans-epithelial permeability.  Decreased levels of trans-epithelial resistance may allow 
cancer-causing agents to diffuse easily through the tissue (Bernstein & Lacey, 2011; 
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Martin, Das, Mansel, & Jiang, 2007).  Cancer cells may fail to promote the expression of 
unique receptors on the cell to signal the immune system to execute apoptosis via 
cytotoxic T cells (Martin, et al., 2007; L. Vona-Davis & Rose, 2009).  The cancer cells 
are able to proliferate without mediation from the immune system resulting in metastasis 
(Jerry, Dunphy, & Hagen, 2010; Martin, et al., 2007).   
However, research is still inconclusive over the exact pathology of breast cancer 
pathology.  We now know it is not one gene, one risk factor, or one event that causes 
breast cancer (Bernstein & Lacey, 2011; Milne et al., 2010; Phipps, et al., 2011).  Instead, 
we can conclude that there are numerous genes, factors, and events that contribute to the 
pathology of breast cancer.   
Tumor Receptors 
Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth 
factor  (HER2) are three tumor markers used to diagnose, determine treatment, and 
classify subtypes of breast cancer (Albrektsen, Heuch, & Thoresen, 2010).  Researchers 
have used these tumor markers to investigate the risk factors of breast cancer subtypes 
and the aggressiveness of each subtype (Bernstein & Lacey, 2011).  Estrogen receptor-
positive and progesterone receptor-positive tumor markers have been characterized to 
have more favorable responses to hormonal therapy and better prognoses (Bernstein & 
Lacey, 2011; Jerry, et al., 2010).  Research proposes reproductive, socioeconomic, and 
lifestyle influences to predict specific tumor receptor markers in females with breast 
cancer (Bernstein & Lacey, 2011; Burris & Andrykowski, 2010; McGarvey, et al., 2011).  
Various subtypes have been associated with different rates of mortality, pathology, and 
response to standardized treatment methods Over expressions of tumor receptors have 
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been correlated with tumor cell proliferation in conjunction with mutations in tumor 
suppressing genes and imbalances in regulating proteins (Jerry, et al., 2010; Lari & 
Kuerer, 2011; Perks & Holly, 2011).  A subtype of breast cancer, characterized as 
estrogen receptor-negative/progesterone receptor-negative/human epidermal growth 
factor receptor 2 negative subtype, also known as “triple-negative,” may have risk factors 
that are hormonally or non-hormonally stimulated (Phipps, et al., 2011; Rakha et al., 
2009).  In 2011, Phipps et. al. found nulliparity to be associated with an increased risk of 
estrogen receptor-positive breast cancer, but it was not associated with the risk of 
estrogen receptor-negative or triple-negative breast cancer (2011).  Various researchers 
have associated this aggressive, unconventional subtype of breast cancer with poor 
socioeconomic factors in rural populations (Abraham, et al., 2009; L. Vona-Davis, et al., 
2008).  Additional research has also associated obesity, race, young age, and a possible 
genetic anomaly with this triple-negative breast cancer subtype (McGarvey, et al., 2011; 
Linda Vona-Davis & Rose, 2009).  However, research investigating these tumor receptor 
markers related to the vital status of adverse socioeconomic regions, specifically the 
Appalachian region of Kentucky, is novel and limited.   
Reproductive Factors 
Research concludes parity, early age of first pregnancy, and premenopausal status 
are negatively associated with breast cancer risk in women (Albrektsen, et al., 2010; 
Huiyan et al., 2010; Milne, et al., 2010).  Research has found high parity to be negatively 
associated with breast cancer mortality in adult women (Phipps, et al., 2011).  One study 
observed a 50% decrease in breast cancer incidence, with a full term pregnancy early in 
reproductive life (Jerry, et al., 2010).    Research studies have attributed this decreased 
7 
 
risk of breast cancer development to the decreased oscillation of these hormones during 
pregnancy versus the nulliparous state (Jerry, et al., 2010; Ursin, et al., 2005).  Obesity in 
premenopausal women has been correlated with a protective effect against the 
development of breast cancer, specifically affecting the levels of endogenous circulation 
of ovarian hormones (Conroy et al., 2011; Smigal et al., 2006).  Premenopausal breast 
cancer has been associated with more aggressive tumor subtypes, larger tumor sizes, 
increased lymphatic involvement, and increased recurrence. On the other hand, 
postmenopausal status has been associated with less aggressive hormone-stimulated 
tumor receptor markers in females with breast cancer (Conroy et al., 2011; Smigal, et al., 
2006; Vona-Davis & Rose, 2009).  Yet, postmenopausal obesity has been linked to an 
increased risk of breast cancer incidence and decreased vital status.  Increased 
postmenopausal adipose tissue is thought to stimulate an overproduction of endogenous 
hormones that promotes the formation of abnormal breast cells (Conroy, et al., 2011; 
Smigal, et al., 2006; Vona-Davis & Rose, 2009).  Available epidemiological and hospital 
record data for Kentucky limits the ability of researchers to correlate obesity to hormone 
stimulated tumor receptor status and mortality rate in both the Appalachian and Non-
Appalachian region.  Therefore, future development of data collection methods including 
dietary and anthropometric fields could better promote the development of a better breast 
cancer mortality rate prediction model.     
Regional Differences 
The Appalachian region represents 52 of the 120 counties in the state of Kentucky 
(Kentucky Cancer Registry, 2011).  This region has been historically categorized as 
medically underserved with poor socioeconomic conditions (Hall, et al., 2002).   Current 
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literature suggests a need for more research to investigate how socioeconomic factors 
influence the mortality rate of women with breast cancer.  Researchers hypothesize that 
various socioeconomic factors, in addition to tobacco use, reproductive factors, and 
genetics have an impact on breast cancer vital status (Huang, Dignan, Han, & Johnson, 
2009; Land et al., 2011; L Vona-Davis & Royce, 2009).  Poor socioeconomic factors, 
including low education rates, low average annual salary, and decreased access to health 
care have been correlated to high rates of breast cancer incidence (Burris & 
Andrykowski, 2010; McDavid, et al., 2003; Royse & Dignan, 2009).   
According to the Appalachian Regional Commission (2009), the average annual 
salary of the Appalachian region of Kentucky is $28,979.  The socioeconomic status of 
this region is of concern since this average salary is more than $5000 less than the 
national and state averages and $4,818 less than the remaining United States Appalachian 
region. Consequently, this region has the highest poverty rate and lowest high school 
graduation rate in all Appalachia (ARC, 2009). 
Previous research focusing on cancer knowledge and screening intentions 
concluded access to health care to be an important predictor of cancer vital status in the 
Appalachian region of Kentucky (McDavid, et al., 2003; Royse & Dignan, 2009).  In 
2009, Royce and Dignan associated decreased health insurance coverage and screening 
education with low levels of screening procedures.   The study discovered over 25% of 
the study participants did not know there was a test for breast cancer and over half were 
unable to identify at least one warning sign of cancer.  The population with the lowest 
education level was most likely to be among the 56.5% of participants that were unable to 
identify any of these warning signs (Royse & Dignan, 2009). The findings provide 
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evidence to suggest the Appalachian region of Kentucky is less educated about 
preventative measures and the symptoms of breast cancer (Huang, et al., 2009; Royse & 
Dignan, 2009).    
Research investigating populations in the Appalachian counties of Virginia also 
found socioeconomic factors, such as low income, lack of education, and decreased 
access to medical care, to contribute to adverse health disparities in Appalachian regions 
(McGarvey, et al., 2011). However, this study failed to significantly correlate health 
insurance coverage to health care utilization.  
 Research concludes populations in Appalachia are less likely to seek medical care 
due the inconvenient travel associated with seeking specialized care and the lack of 
income and insurance coverage to pay medical fees (Burris & Andrykowski, 2010; 
Huang, et al., 2009; McDavid, et al., 2003). As a result, individuals are procrastinating 
medically necessary screening procedures and delaying preventative care (Royse & 
Dignan, 2009).  More research involving socioeconomic factors is imperative to generate 
a more accurate prediction model for breast cancer vital status. 
Tumor Classifications by Stage and Grade 
Tumor classifications by stage and grade, are used by medical professionals and 
researchers to classify the physical characteristics of cancer cells (Young, Roffers, Reis, 
Fritz, & Hurlburt, 2001).   Poor socioeconomic factors are linked to less optimal breast 
cancer classifications (L Vona-Davis & Royce, 2009).  Prolonged diagnosis is associated 
with a more aggressive breast cancer progression, more invasive cancer, and negative 
vital status (Huang, et al., 2009).  The delayed utilization of health care and screening 
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procedures may accompany a later stage and higher tumor grade of breast cancer at 
diagnosis (Hall, et al., 2002).   
The National Cancer Institute’s Surveillance Epidemiology and End Results 
classification system is used to classify the progression stage of breast cancer.  According 
to the 2000 SEER Summary Staging Manual, Stage I is defined as a localized cancer. “A 
localized cancer is a malignancy limited to the organ of origin” (Young, et al., 2001).  
The cancerous cells are in the fat and breast tissue, which includes the nipple and/or 
areola, and have not metastasized to other organs of the body.  A cancer is upgraded to 
Stage II when it is no longer confined to the breast tissue.  Specifically, the cancer has 
infiltrated a surrounding tissue or muscle.  The cancer is defined as Stage III when the 
cancer has spread into the lymphatic system.  When the cancer has metastasized in other 
organs of the body via tissue and lymphatic system, the breast cancer is categorized as 
Stage IV.   A less known classification, Stage VII breast cancer is defined as a distant 
metastasis with lymphatic involvement. For example, a woman is classified as having 
Stage IV if her primary location of cancer is in the breast with a satellite metastasis in the 
adrenal gland (Young, et al., 2001).  However, it is important to understand there are 
limitations to the staging system.  Research involving the incorporation of breast cancer 
staging may have an increased margin of error depending on the variability of physician 
differentiation characteristics and on the ability to accurate classify to cancer associated 
with degree of metastatic clarity (Young, et al., 2001).  
According to Young et al., (2001), the National Cancer Institute defines tumor 
grade as “a system used to classify cancer cells in terms of how abnormal they look under 
a microscope and how quickly the tumor is likely to grow and spread.” The scale is 1 – 4, 
11 
 
with 1 being well differentiated to 4 being undifferentiated or anaplastic.   Grade 4 
tumors are considered the most aggressive grade (Young, et al., 2001).  Research 
investigating breast cancer history related to reproductive factors in a Norwegian 
population provided evidence to support previous research works associating prolonged 
diagnosis, later age at diagnosis, and nulliparity to be associated with a higher 
histological grade of breast cancer tumors (Albrektsen, et al., 2010).  Poorly 
differentiated tumors were most associated with younger age, with the most significance 
in nulliparious women. This study emphasized a large gap in breast cancer research.  
Current research fails to unify the associations of tumor classifications, reproductive 
factors, and socioeconomic influences to breast cancer vital status. 
Future researchers should analyze these risk predictors with tumor receptors to 
investigate if poorly differentiated tumors in young, nulliparious women are associated 
with triple-negative breast cancer.  In addition, socioeconomic factors related to tumor 
classifications controlling for reproductive and lifestyle factors would construct a more 
valid prediction model for breast cancer vital status. 
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CHAPTER THREE 
Methodology 
Research Methods 
This research study was approved by the Institutional Review Board (IRB) at the 
University of Kentucky, in April 2011.  Once the study was approved, applications were 
submitted to the Kentucky Cancer Registry to obtain research data fields.  Permission to 
use the data was granted by the Kentucky Cancer Registry review panel in May 2011.  
The Kentucky Cancer Registry informatics staff created a de-identified data file that was 
transferred over the Kentucky Cancer Registry secure transfer site.  The data was 
accessed using an assigned username and password.  The data included individual, 
record-level data with no personal identifiers. 
This study used a cross-sectional observational epidemiologic framework.  The 
data supplied by the Kentucky Cancer Registry provided demographic, reproductive, 
histological, and lifestyle information for analysis. 
Research Scope 
 The study used all primary cases of breast cancer in adult females, age 18 and 
over, living in Kentucky between years 2004 and 2007.     
Study Population 
 The study population included all female breast cancer cases in Kentucky from 
2004-2007.  The original sample included 11,822 breast cancer records in the female 
population of 8,543,939 at risk (Kentucky Cancer Registry [KCR], 2011).   Women that 
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died due to accidental events not associated with medical diagnosis were excluded from 
this study and thus, did not contribute to case analysis.  After excluding cases not meeting 
parameters of the study project, 11,814 cases were used for the statistical analysis.  The 
final study population included 8642 Non-Appalachian and 3172 Appalachian women.    
Statistical Analysis 
This study used SPSS ® Version 20 to assess breast cancer mortality among adult 
females with breast cancer living in Kentucky between 2004 and 2007. Descriptive 
statistics and chi-square analyses were calculated to compare ethnicity, residence, 
tobacco use, number of live births, and estrogen and progesterone receptor tumor status 
between the Appalachian and Non-Appalachian region of Kentucky.  Separate adjusted 
and unadjusted multivariate logistic regression models were constructed for parity, 
region, and tumor receptor status.  Mortality was considered the dependent variable.  The 
full model adjusted for age, ethnicity, tumor status, tumor grade, tumor stage, family 
history, tobacco use, and menopausal status.  An additional multivariate logistic 
regression model used backward elimination to analyze the interactions of the full-
adjusted model.   
Number of live births, the main variable, was divided into 5 categories --- 0, 1, 2, 
3 and 4 or more live births (Whiteman et al., 2004).  Tobacco use was categorized as “yes 
tobacco use” or “no tobacco use,” considering cigarette, cigar, and chewing tobacco 
history. Tumor grade was categorized according to the clinical TNM stage grouping from 
the cTNM classification using the AJCC Cancer Staging Manual as tumor grade I, II, III, 
and IV (KCR, 2011).  Tumor stage was coded according to Kentucky Cancer Registry’s 
coding protocol using coding guidelines in Appendix C of the SEER Program Coding 
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and Staging Manual (KCR, 2011).   Tumor stage was further categorized as “early stage” 
and “late stage.”  Tumors that were “SEER Stage I” and “SEER Stage II” were 
considered “early stage.”  Tumors that were advanced past SEER Stage II were 
considered “late stage” (Huang, et al., 2009).  Race was categorized as white, or non-
white (McDavid, et al., 2003).  Recurrence was categorized as recurred or non-recurring 
breast cancer.  Estrogen receptor and Progesterone receptor tumor status was considered 
positive or negative.   An additional variable, age at diagnosis, was created subtracting 
date of birth from date of diagnosis (Albrektsen, et al., 2010).  Tumor behavior was 
considered invasive or in-situ.  Family history, number of primaries, and menopausal 
status were also included in the model.  Postmenopausal status was assumed for 
incomplete data fields with age greater than or equal to 65 years old.  The entire data set 
was received from the Kentucky Cancer Registry stratified by region according to 
residence in the Appalachian and Non-Appalachian region of Kentucky.  Appalachian 
counties were designated by the Kentucky Cancer Registry as the 52 following counties:  
Adair, Bath, Bell, Boyd, Breathitt, Carter, Casey, Clark, Clay, Clinton, Cumberland, 
Elliott, Estill, Fleming, Floyd, Garrard, Green, Greenup, Harlan, Jackson, Johnson, Knott, 
Knox, Laurel, Lawrence, Lee, Leslie, Letcher, Lewis, Lincoln, Madison, Magoffin, 
Martin, McCreary, Menifee, Metcalfe, Monroe, Montgomery, Morgan, Nicholas, 
Owsley, Perry, Pike, Powell, Pulaski, Robertson, Rockcastle, Rowan, Russell, Wayne, 
Whitley, Wolfe. 
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This study used a cross-sectional observational epidemiologic framework.  The 
data supplied by the Kentucky Cancer Registry provided demographic, reproductive, 
histological, and lifestyle information for analysis. 
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CHAPTER FOUR 
Results 
Demographics 
Demographic characteristics for the breast cancer registry patients in Kentucky 
are listed in Table 1.   From 2004 – 2007, 93.3% of the population was white with 26.8% 
of women with breast cancer in Kentucky were living in the Appalachian region and 
73.20% living in the Non-Appalachian region of Kentucky.   The mean age of diagnosis 
was 61.03 years of age.  Progesterone receptor-positive and estrogen receptor tumor 
status was predominantly positive with 64.2% and 75.9%, respectively.  More than 60% 
of the women were non-smokers.  The number of live births for women with breast 
cancer in Kentucky was 12.8%, 19.9%, 32.6%, 18.8%, and 15.8% for no live births, one, 
two, three, and four or more live births, respectively.  
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Table 1. Demographic Characteristics of Breast Cancer Registry Patients in 
Kentucky, 2004-2007. 
 
   Mean (SD) or Percentage 
Ethnicity   
White 93.3% 
Non-White 6.8% 
Age 61.03 (13.84) 
Residence   
Appalachia resident 26.8% 
Non-Appalachia resident 73.2% 
Progesterone Receptor    
PR+ 64.2% 
PR- 35.8% 
Estrogen Receptor   
ER+ 75.9% 
ER- 24.4% 
Tobacco Use   
No 60.7% 
Yes 39.3% 
Number of Live Births   
0 12.8% 
1 19.9% 
2 32.6% 
3 18.8% 
4 or greater 15.8% 
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Reproductive Differences 
The data in Table 2 show that one live birth and three live births significantly 
increases an adult woman’s risk of breast cancer mortality by 91% and 58%, respectively, 
after adjusting for age, ethnicity, tumor status, family history, tobacco use, tumor grade, 
menopausal status, tumor behavior, tumor stage, and region in Kentucky. Before 
adjusting for these factors, one, two, and three live births were not significant in 
predicting mortality among adult women living in Kentucky during 2004 and 2007.  
However, four or more live births did show a significant 57% increase in breast cancer 
mortality.  The adjusted and unadjusted models had an overall p-value <.001. 
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Tumor Receptor Status 
The data in Table 3 show that progesterone receptor-negative tumor status 
significantly increases an adult woman’s risk of breast cancer mortality by 64% after 
adjusting for age, ethnicity, tumor status, family history, tobacco use, tumor grade, parity, 
menopausal status, tumor behavior, tumor stage, and region in Kentucky.  Estrogen 
receptor status was not a significant predictor in the adjusted model.  Both estrogen 
receptor and progesterone receptor-negative status was associated with a significant 
increase in a woman’s risk for breast cancer mortality between 2004 and 2007, 
unadjusted for other covariates.  A backwards elimination logistic regression model 
showed a significant interaction between Appalachia and progesterone receptor tumor 
status.  The resulting odds ratio of the interaction model showed a 3.13 fold increase in 
breast cancer mortality for a woman with progesterone receptor-negative breast cancer 
living in the Appalachian region compared to a women with progesterone receptor-
negative in the Non-Appalachian Kentucky between 2004 and 2007.  The adjusted and 
unadjusted models had an overall p-value <.001. 
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Regional Differences 
The data in Table 4 show that women with breast cancer living in the Appalachian 
region of Kentucky between 2004 and 2007 have a 1.23 fold unadjusted and 3.14 fold 
adjusted increase in breast cancer mortality risk compared to women with breast cancer 
in Non-Appalachia.   A Pearson’s chi-square confirmed the mortality rate among women 
in Kentucky with breast cancer was significantly different with a 19.6% mortality rate in 
the Appalachian region, compared to 16.6% mortality rate in the Non-Appalachian region 
of Kentucky. The mortality difference is consistent with the literature and government 
statistics (Halverson et al., 2004).   
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CHAPTER FIVE 
Discussion 
The purpose of this study is to investigate the breast cancer mortality rate 
differences among women living in the Appalachian and Non-Appalachian regions of 
Kentucky.  Specifically, the research questions aimed to determine if the breast cancer 
mortality rate was increased in the Appalachian region of Kentucky due to a more 
aggressive subtype of breast cancer or other socioeconomic, reproductive, or lifestyle 
factors.   
The limitations of this study should be considered when interpreting the results.  
This cross-sectional study is subject to several limitations.  First, this study analyzed 
adult women with breast cancer living in Kentucky between 2004 and 2007.  Therefore, 
the results cannot be extrapolated to women without breast cancer, females under the age 
of 18, men with breast cancer, or women living outside of Kentucky between 2004 and 
2007.  Next, additional factors to define lifestyle, reproductive, and socioeconomic status 
were not analyzed in the model.  Thus, BMI, education, income, environment, genetic 
sequences, age at first pregnancy, age at first menstrual cycle, nutritional status, dietary 
consumption, and other undefined factors were not included in this model.  Yet, the main 
impediment to this research is the degree of missingness of the main variable parity.  In 
addition, excluded incomplete records were more likely to be collected from the 
Appalachian region, which may have also biased the results.  However, multiple 
imputations of all variables with logistic regression, excluding parity, justified the 
selection of the original model.   
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The first research question asked if the number of live births had an effect on the 
breast cancer mortality variation among adult women with breast cancer living in 
Kentucky. The researcher initially expected parity to be negatively associated with 
mortality.  However, the data contradicted this hypothesis.  After further review of 
literature, the researcher found a majority of the previous research to investigate parity 
with breast cancer incidence instead of mortality.  Few studies have examined the 
association of parity after a woman has been diagnosed with breast cancer.  An article in 
2009, highlighted this discrepancy and concluded women with four or more children, 
using data from a Swedish Cancer Registry, were found to have a poorer prognosis 
compared to women with one live birth (S. Butt et al., 2009).  Further review found a 
similar study in U.S. women to yield results concluding parity increases a woman’s risk 
of breast cancer mortality (Whiteman, et al., 2004).  Possible explanations for this result 
would be explained by an enhanced initiation of breast cancer proliferation related to 
pregnancy (Butt, Borgquist, Anagnostaki, Landberg, & Manjer, 2009; Butt, et al., 2009; 
Whiteman, et al., 2004).   During a woman’s lifetime, endogenous hormones oscillate 
according to menstrual cycle and pregnancy (Butt, et al., 2009; Ursin et al., 2005).  These 
endogenous hormones may have an effect on the proliferation of breast cancer cells by 
providing a susceptible physiological state for abnormal cell proliferation (Butt, et al., 
2009; Ursin, et al., 2005).  On the other hand, non-hormonal influences that have not 
been suppressed by the protective effect of parity may also affect the rate of mortality 
(Phipps, et al., 2011; Whiteman, et al., 2004).  In addition, factors such as BMI related to 
increased adipose tissue, menopausal status, and oral contraceptive use may contribute to 
risk estimates observed.  However, the exact effect of parity on the initiation and 
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pathology of breast cancer mortality is still unclear and cannot be defined by this research 
study.  Thus, more invasive research is needed.  
The second research question asked if breast cancer tumor receptor status had an 
effect on mortality in women with breast cancer living in Kentucky.  This study found 
progesterone receptor-negative status to be significantly associated with breast cancer 
mortality in Kentucky.  Furthermore, after adjusting for the other variables and the 
interaction term the study found a significant increase in breast cancer mortality for a 
woman with progesterone receptor-negative breast cancer versus progesterone receptor-
negative breast cancer living in the Appalachian region of Kentucky between 2004 and 
2007.   The researcher did not expect to see the degree of increased risk related to region 
as observed by the data.  Progesterone receptor-negative status is a very aggressive tumor 
subtype characterized to have a poor prognosis (Lari et al, 2011; Phipps et al, 2011).  
These results raise the question if this aggressive tumor subtype’s poor prognosis is 
exacerbated by poor socioeconomic status, as observed in the Appalachian region of 
Kentucky or is there additional unknown cofounders that have not been investigated? 
The third research question asked what factors contribute to the mortality 
difference between the Appalachian and Non-Appalachian region in women with breast 
cancer living in Kentucky.  A logistic regression model concluded a significant increase 
in breast cancer mortality in the Appalachian region of Kentucky.  Progesterone receptor 
status and number of primaries were the most significant in predicting mortality in this 
population.   Literature supports these findings (Smigal, et al., 2006; Ursin, et al., 2005).  
However, a backwards elimination regression model selecting for interactions between 
region versus parity, menopausal status, age at diagnosis, family history, tumor behavior, 
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recurrence, and ethnicity were not significant.  This may be due to the large amount of 
missingness in the data or the small population size of women with breast cancer in years 
2004 to 2007, versus a larger selection of years.  In addition, other risk factors such as 
BMI, education, income, insurance, and travel distance were not included in this model, 
which could have been factors in the increased mortality rates.  Therefore, this data 
cannot reliably provide enough evidence to define the breast cancer mortality rate 
differences between the two regions.  Instead, this data can only confirm that there is a 
difference in mortality between the two regions and that more research is necessary to 
define these interactions.   
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CHAPTER SIX 
Conclusion 
This study concluded reproductive differences and estrogen receptor tumor status 
between the Appalachian and Non-Appalachian region of Kentucky do not contribute to 
the difference in mortality between the two regions.  However, progesterone receptor 
tumor status did provide evidence to suggest aggressive tumor receptor subtype 
differences may contribute to the regional mortality variation.   Progesterone receptor-
negative subtype, an aggressive form of breast cancer, was the most indicative predictor 
of breast cancer mortality in adult women living in the Appalachian region of Kentucky.  
This suggest women in the Appalachian region are more likely to die of breast cancer if 
they have progesterone receptor-negative breast cancer than if they live the Non-
Appalachian region of Kentucky.  However, progesterone receptor-negative status may 
also have addition socioeconomic influences that were not included in the risk 
assessment.  
The results of this study provide some epidemiological evidence that parity, 
receptor subtype, and socioeconomic factors are involved in the risk of breast cancer 
mortality.  Limited research has investigated breast cancer mortality among Kentucky 
women, specifically between the Appalachian and Non-Appalachian regions of 
Kentucky.  In comparison to previous studies that focused on risk assessment of parity to 
incidence of breast cancer, this study analyzed the effect of parity on the risk of breast 
cancer mortality.   This study provided support for the novel research associating 
increased parity to be positively associated with breast cancer mortality.   In addition, this 
study provided support to infer poor socioeconomic factors, associated with the 
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Appalachian region, provide the poorest prognosis for a woman with breast cancer in 
Kentucky.  Socioeconomic, as well as environmental and lifestyle factors unique to the 
Appalachian region such as lower high school graduation rates, increased obesity rates, 
decreased access to healthcare, delayed diagnoses, and poor nutritional statuses may pose 
a significant risk of breast cancer mortality in these Kentucky women.   
These findings have important implications for developing educational, 
preventative, and research techniques to decrease mortality in both the Appalachian and 
Non-Appalachian regions of Kentucky.   Prevention efforts should be aimed at 
addressing and improving socioeconomic factors, increasing access to health care, and 
continued efforts researching the breast cancer risk factors among Kentucky women.   
Early mammograms should be encouraged by establishing funding from organizations to 
provide free mammograms in socioeconomically deprived areas of Kentucky.   In 
addition, Kentucky can take strides to improve cancer registry data quality by 
encouraging hospitals to record accurate and complete data records.  This would decrease 
the amount of missingness in the cancer registry data.  Furthermore, a cancer registry 
database could be developed to include dietary, lifestyle, and socioeconomic data.  This 
database would provide a comprehensive tool for researchers to better define risk factors 
associated with breast cancer.   
Future investigation is needed to better establish risk assessment models 
incorporating socioeconomic, reproductive, and lifestyle factors to aid in the prevention 
of breast cancer mortality in Kentucky women. Prospective studies should compare 
breast cancer data between Area District Development Regions to better categorize 
socioeconomic influences.  Current research also shows nutritional status may prove to 
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be an important predictor in the vital status of breast cancer.    The proposed research 
should analyze Kentucky breast cancer medical data against dietary and socioeconomic 
data.  Future research efforts are warranted to define the relationship between dietary 
intake and subtypes by controlling for socioeconomic factors.  In conclusion, 
socioeconomic influences related to nutritional status, lifestyle factors, and reproductive 
factors are an important topic for further study.   
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Appendix B:  Definition of Terms 
Appalachian region of Kentucky – 52 counties in the state of Kentucky which include 
Adair, Bath, Bell, Boyd, Breathitt, Carter, Casey, Clark, Clay, Clinton, Cumberland, 
Elliott, Estill, Fleming, Floyd, Garrard, Green, Greenup, Harlan, Jackson, Johnson, Knott, 
Knox, Laurel, Lawrence, Lee, Leslie, Letcher, Lewis, Lincoln, Madison, Magoffin, 
Martin, McCreary, Menifee, Metcalfe, Monroe, Montgomery, Morgan, Nicholas, 
Owsley, Perry, Pike, Powell, Pulaski, Robertson, Rockcastle, Rowan, Russell, Wayne, 
Whitley, Wolfe (Kentucky Cancer Registry, 2011) 
Nulliparity –  Zero live births of a woman (Salma Butt, et al., 2009) 
Number of live births – Refers to the actual number of offspring born alive. (Kentucky 
Cancer Registry, 2011) 
Number of primaries - Number of recorded primary cancer sites (Kentucky Cancer 
Registry, 2011) 
Parity – Number of live children born from a woman (Salma Butt, et al., 2009; Ursin, et 
al., 2005) 
Tumor-receptor – protein biological marker on the surface of a cancer cell (Bernstein & 
Lacey, 2011; Jerry, et al., 2010; Lari & Kuerer, 2011) 
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